Ilona C. Enninga
Algemeen Directeur bij Amphera BV
Actieve functies van Ilona C. Enninga
| Bedrijven | Functie | Begin | Einde |
|---|---|---|---|
| Charles River Laboratories Den Bosch BV | Hoofd Techniek/Wetenschap/O&O | 01-01-1992 | - |
Amphera BV
 Amphera BV BiotechnologyHealth Technology Amphera BV develops an immunotherapy for cancer induced by asbestos. It triggers the patient?s own immune defense system, growth of cancer cells may be stopped or inhibited. The company was founded in December 2012 and is headquartered s-Hertogenbosch, the Netherlands. | Algemeen Directeur | - | - |
Loopbaan van Ilona C. Enninga
Eerdere bekende functies van Ilona C. Enninga
| Bedrijven | Functie | Begin | Einde |
|---|---|---|---|
| University of Leiden | Corporate Officer/Principal | - | - |
| Charles River Laboratories Den Bosch BV | Corporate Officer/Principal | - | - |
Immunovo BV
 Immunovo BV BiotechnologyHealth Technology Immunovo BV develops immune therapeutics in the field of oncology. The firm's research focuses on therapeutic vaccines based on synthetic peptide antigens for which the company applies the novel and proprietary techniques in synthetic immunogen development. Its products include Sclerostin, PD1, PEPA10-adj, Gastrine, VEGF, and GnRH. The company was founded in 2009 and is headquartered in ‘s-Hertogenbosch, the Netherlands. | Operationeel Directeur | - | - |
Opleiding van Ilona C. Enninga
| University of Leiden | Undergraduate Degree |
Statistieken
Internationaal
| Nederland | 5 |
Operationeel
| Corporate Officer/Principal | 2 |
| Chief Operating Officer | 1 |
| Chief Tech/Sci/R&D Officer | 1 |
Sectoraal
| Health Technology | 3 |
| Consumer Services | 2 |
Beklede functies
Actief
Inactief
Beursgenoteerde bedrijven
Bedrijven in privébezit
Verwante bedrijven
| Bedrijven in privébezit | 3 |
|---|---|
Immunovo BV
Immunovo BV BiotechnologyHealth Technology Immunovo BV develops immune therapeutics in the field of oncology. The firm's research focuses on therapeutic vaccines based on synthetic peptide antigens for which the company applies the novel and proprietary techniques in synthetic immunogen development. Its products include Sclerostin, PD1, PEPA10-adj, Gastrine, VEGF, and GnRH. The company was founded in 2009 and is headquartered in ‘s-Hertogenbosch, the Netherlands. | Health Technology |
| Charles River Laboratories Den Bosch BV | |
Amphera BV
Amphera BV BiotechnologyHealth Technology Amphera BV develops an immunotherapy for cancer induced by asbestos. It triggers the patient?s own immune defense system, growth of cancer cells may be stopped or inhibited. The company was founded in December 2012 and is headquartered s-Hertogenbosch, the Netherlands. | Health Technology |
- Beurs
- Insiders
- Ilona C. Enninga
- Ervaring
